Literature DB >> 2255558

The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates.

C S Ong1, K Y Zhang, S J Eida, P M Graves, C Dow, M Looker, N C Rogers, P L Chiodini, G A Targett.   

Abstract

Thirty serum samples collected from adult patients attending the Hospital for Tropical Diseases, London, with P. falciparum malaria, were studied. Sera were screened by indirect immunofluorescence for anti-gametocyte antibodies. Twelve of the serum samples taken from 14 patients with primary infections were found to have both IgM and IgG antibodies to gametocyte antigens and total Ig titres comparable with those of patients who had had previous malaria attacks. Sera of individuals from hyperendemic areas have been found to immunoprecipitate the 230 and 48/45 kD gametocyte surface antigens which are known targets of transmission blocking antibodies. To investigate the epitope specificity of the serum samples from our adult patients, competitive ELISAs with 3 monoclonal antibodies (MAbs) that block transmission and recognize different epitopes on the 48/45 Kd antigen, were carried out. Specific antibodies for these epitopes were found in 60% of the sera while nearly a third were able to inhibit the binding of at least two MAbs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2255558     DOI: 10.1111/j.1365-3024.1990.tb00980.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  14 in total

1.  Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.

Authors:  B Wizel; N Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.

Authors:  André Lin Ouédraogo; Will Roeffen; Adrian J F Luty; Sake J de Vlas; Issa Nebie; Edith Ilboudo-Sanogo; Nadine Cuzin-Ouattara; Karina Teleen; Alfred B Tiono; Sodiomon Bienvenu Sirima; Jan-Peter Verhave; Teun Bousema; Robert Sauerwein
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

3.  A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum.

Authors:  Christine E Farrance; Amy Rhee; R Mark Jones; Konstantin Musiychuk; Moneim Shamloul; Satish Sharma; Vadim Mett; Jessica A Chichester; Stephen J Streatfield; Will Roeffen; Marga van de Vegte-Bolmer; Robert W Sauerwein; Takafumi Tsuboi; Olga V Muratova; Yimin Wu; Vidadi Yusibov
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

4.  Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes.

Authors:  A H Lensen; M Bolmer-Van de Vegte; G J van Gemert; W M Eling; R W Sauerwein
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

5.  The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.

Authors:  Teun Bousema; Will Roeffen; Hinta Meijerink; Harry Mwerinde; Steve Mwakalinga; Geert-Jan van Gemert; Marga van de Vegte-Bolmer; Frank Mosha; Geoffrey Targett; Eleanor M Riley; Robert Sauerwein; Chris Drakeley
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

6.  Human immune responses that reduce the transmission of Plasmodium falciparum in African populations.

Authors:  Teun Bousema; Colin J Sutherland; Thomas S Churcher; Bert Mulder; Louis C Gouagna; Eleanor M Riley; Geoffrey A T Targett; Chris J Drakeley
Journal:  Int J Parasitol       Date:  2010-10-23       Impact factor: 3.981

7.  Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.

Authors:  Louise Turner; Christian W Wang; Thomas Lavstsen; Steven B Mwakalinga; Robert W Sauerwein; Cornelus C Hermsen; Thor G Theander
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

Review 8.  Malaria vaccines and their potential role in the elimination of malaria.

Authors:  Geoffrey A Targett; Brian M Greenwood
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

9.  Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.

Authors:  Andres F Vallejo; Nora L Martinez; Alejandra Tobon; Jackeline Alger; Marcus V Lacerda; Andrey V Kajava; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Malar J       Date:  2016-04-12       Impact factor: 2.979

10.  Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.

Authors:  Prasun Kundu; Anthony Semesi; Matthijs M Jore; Merribeth J Morin; Virginia L Price; Alice Liang; Jingxing Li; Kazutoyo Miura; Robert W Sauerwein; C Richter King; Jean-Philippe Julien
Journal:  Nat Commun       Date:  2018-10-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.